Health Condition 1: - Health Condition 2: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: QURS-E-LUK: 2.5gm-BD,with water, after meal, with 4 follow ups at interval of 15 days.
Control Intervention1: Tablet Atorvastatin-40 mg: OD-with water after meal, with 4 follow ups at
Sponsors
PG Dept. of Moalijat
Eligibility
Inclusion criteria
Inclusion criteria: 1.Diagnosed cases of primary hyperlipidemia is selected for this clinical trial . 2.Patient with Serum Triglycerides (TG) more than 200-499 mg/dl , and Serum LDL Cholestrol more than 160-189 mg/dl, Serum Total Cholestrol more than 240 mg/dl,and VLDL less than30mg/dl. HDL Cholestrol up to 50 mg/dl included in this study.
Exclusion criteria
Exclusion criteria: 1.Pregnant & Lactating women 2.Severe active coronary artery disease & Ischemic Heart disease. 3. Uncontrolled DM 4.Alcoholism 5.Mentally retarded patients. 6.Patients with severe systemic disease & organ failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To reduce the abnormal elevated range of Triglycerides,serum LDL and VLDL cholesterol, serum total Cholesterol.and maintain normal HDL Cholesterol up to 50mg/dl.Timepoint: once in 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To maintain body weight, and reduce the risk factor of cardiovascular diseases.Timepoint: once in 2 weeks | — |
Countries
India
Contacts
Public ContactDr Fareeha Kausar
Govt. Nizamia Tibbi College and General hospital
Outcome results
None listed